William Plovanic
Stock Analyst at Canaccord Genuity
(3.47)
# 908
Out of 5,057 analysts
159
Total ratings
45.77%
Success rate
5.17%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $399 → $428 | $332.96 | +28.54% | 6 | Nov 7, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $51 | $45.60 | +11.84% | 4 | Nov 7, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $9 → $11 | $8.89 | +23.73% | 9 | Nov 6, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $81 → $84 | $86.17 | -2.52% | 28 | Nov 3, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $193 → $212 | $168.63 | +25.72% | 13 | Oct 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 → $99 | $59.71 | +65.80% | 9 | Oct 31, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $142 → $147 | $115.75 | +27.00% | 8 | Oct 30, 2025 | |
| ATRC AtriCure | Maintains: Buy | $53 → $64 | $31.77 | +101.45% | 12 | Oct 30, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $132 | $104.99 | +25.73% | 12 | Oct 23, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $17 → $18 | $12.31 | +46.28% | 8 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 | $17.52 | +37.03% | 6 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $39 | $30.99 | +25.87% | 2 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.03 | +244.83% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $83.91 | +7.26% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $90.32 | +11.82% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $4.39 | +150.66% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $12.44 | +165.27% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.55 | +98.68% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $278.75 | +1.88% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $20.22 | +23.64% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.60 | +650.00% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $87.41 | -19.92% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $26.04 | +84.33% | 5 | Aug 3, 2023 |
Insulet
Nov 7, 2025
Maintains: Buy
Price Target: $399 → $428
Current: $332.96
Upside: +28.54%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $45.60
Upside: +11.84%
CVRx, Inc.
Nov 6, 2025
Maintains: Buy
Price Target: $9 → $11
Current: $8.89
Upside: +23.73%
Edwards Lifesciences
Nov 3, 2025
Maintains: Hold
Price Target: $81 → $84
Current: $86.17
Upside: -2.52%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $193 → $212
Current: $168.63
Upside: +25.72%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $106 → $99
Current: $59.71
Upside: +65.80%
TransMedics Group
Oct 30, 2025
Maintains: Buy
Price Target: $142 → $147
Current: $115.75
Upside: +27.00%
AtriCure
Oct 30, 2025
Maintains: Buy
Price Target: $53 → $64
Current: $31.77
Upside: +101.45%
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $132
Current: $104.99
Upside: +25.73%
AngioDynamics
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $12.31
Upside: +46.28%
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $17.52
Upside: +37.03%
Sep 22, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $30.99
Upside: +25.87%
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.03
Upside: +244.83%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $83.91
Upside: +7.26%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $90.32
Upside: +11.82%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $4.39
Upside: +150.66%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $12.44
Upside: +165.27%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.55
Upside: +98.68%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $278.75
Upside: +1.88%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $20.22
Upside: +23.64%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.60
Upside: +650.00%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $87.41
Upside: -19.92%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $26.04
Upside: +84.33%